Amedisys (AMED) Scheduled to Post Earnings on Tuesday

Amedisys (NASDAQ:AMED) is set to release its earnings data after the market closes on Tuesday, February 27th. Analysts expect Amedisys to post earnings of $0.58 per share for the quarter.

Shares of Amedisys (NASDAQ:AMED) opened at $56.46 on Tuesday. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.33 and a quick ratio of 1.33. Amedisys has a 1 year low of $45.60 and a 1 year high of $65.91. The stock has a market cap of $1,920.00, a P/E ratio of 44.81, a price-to-earnings-growth ratio of 1.15 and a beta of 0.73.

Several brokerages have issued reports on AMED. BidaskClub raised shares of Amedisys from a “strong sell” rating to a “sell” rating in a research report on Wednesday, February 7th. Zacks Investment Research downgraded shares of Amedisys from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Mizuho reaffirmed a “buy” rating and issued a $65.00 price objective (up previously from $55.00) on shares of Amedisys in a research report on Wednesday, November 8th. Benchmark reaffirmed a “hold” rating on shares of Amedisys in a research report on Thursday, November 9th. Finally, Craig Hallum reaffirmed a “buy” rating and issued a $68.00 price objective (up previously from $55.00) on shares of Amedisys in a research report on Thursday, November 9th. One analyst has rated the stock with a sell rating, five have given a hold rating and seven have given a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $60.64.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://stocknewstimes.com/2018/02/20/amedisys-amed-scheduled-to-post-earnings-on-tuesday.html.

Amedisys Company Profile

Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.

Earnings History for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply